|
|
Volumn 317, Issue 5843, 2007, Pages 1305-
|
|
Biomedicine: HIV Drug shows promise as potential cancer treatment
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
NELFINAVIR;
PROTEIN KINASE B;
PROTEINASE INHIBITOR;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
AUTOPHAGY;
CANCER;
CANCER RESEARCH;
DRUG MECHANISM;
DRUG SAFETY;
ENZYME INHIBITION;
HEALTH CARE ORGANIZATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERLIPIDEMIA;
LIPID STORAGE;
MAXIMUM TOLERATED DOSE;
NOTE;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
HIV PROTEASE INHIBITORS;
HUMANS;
MICE;
NELFINAVIR;
|
|
EID: 34548684745
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.317.5843.1305 Document Type: Note |
|
Times cited : (8)
|
|
References (0)
|